Archive - February 2019
EMA suspends fenspiride medicines due to heart rhythm risks
CMS proposes coverage scheme for CAR-T therapies
UCB to form a research satellite facility within King’s College London
Innovate UK awards AKLRD £675,000 for osteoarthritis drug
Darolutamide shows promise for treatment of prostate cancer
MSD testing Keytruda combos for prostate cancer
Opdivo/Yervoy combo successful in castration-resistant prostate cancer
Rexulti falls short of goal in late-stage bipolar disorder studies